NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
19.99
0.86 (4.50%)
At close: May 01, 2025, 3:59 PM
20.03
0.20%
After-hours: May 01, 2025, 04:37 PM EDT
NewAmsterdam Pharma Revenue
NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending December 31, 2024, NewAmsterdam Pharma generated $12.77M in revenue.
Revenue (ttm)
$45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
$670.04K
Employees
68
Market Cap
2.2B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 45.56M | +257.00% |
| Dec 31, 2023 | 12.76M | -86.69% |
| Dec 31, 2022 | 95.91M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |